缬沙坦辅助治疗原发性高血压的临床疗效观察

目的:观察缬沙坦辅助治疗原发性高血压的临床疗效.方法:选取我院自2006年1月至2009年12月收治的216例原发性高血压患者随机分为观察组(缬沙坦辅助治疗)和对照组(常规治疗组)各108例,治疗周期均为8周,观察比较两组的治疗效果.结果:观察组显效64例,有效38例,总有效率为94.5%;对照组显效47例,有效41例...

Efficacy of Valsartan Adjuvant Treatment for Essential Hypertension

Objective： To observe the valsartan assisted the clinical efficacy of treatment for essential hypertension.Method： From January 2006 to December 2009,216 cases of primary hypertension treated in our Hospital were randomly divided into two groups（valsartan adjuvant therapy） and control group（conventional treatment group） each with 108 cases,treatment cycle lasted 8 weeks,the curative effects were observed and compared.Result： 64 cases were excellent,effective in 38 cases,total effective rate was 94.5%;In control group,47 cases was markedly effective,effective in 41 cases,total effective rate was 81.4%.There＇s significant difference between the two groups（P 0.01）.In the 8-week course of treatment,two patients had serious adverse reactions,adverse events rate between the two groups no significant difference（P 0.05）,not statistically significant.Conclusion： Valsartan adjuvant treatment of primary hypertension can significantly improve the treatment effect,It is worthy of clinical use.